Bhi Co., Ltd.
Records under this name other than the patents Bhi Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,238,611 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,857,109 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,360 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,499,480 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,748,656 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,835,500 | Pharmaceutical Formulations of Amyloid Inhibiting Compounds Formerly held Term ended Term ended Nov 26, 2025 · High confidence | Term ended | Term ended Nov 26, 2025 | High confidence |
| US 7,414,076 | Methods and compositions for treating amyloid-related diseases Lapsed on the fee record Ended Aug 19, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2020 | From the USPTO record |
| US 8,044,100 | Methods and compositions for treating amyloid-related diseases Lapsed on the fee record Ended Oct 25, 2019 · From the USPTO record | Lapsed on the fee record | Ended Oct 25, 2019 | From the USPTO record |
| US 9,051,248 | Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid Lapsed on the fee record Ended Jun 9, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2019 | From the USPTO record |
| US 8,835,654 | Method and compositions for treating amyloid-related diseases Lapsed on the fee record Ended Sep 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2018 | From the USPTO record |